1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HEXA CTRPv2 pan-cancer AAC -0.17 5e-07
mRNA PICALM CTRPv2 pan-cancer AAC -0.17 5e-07
mRNA ZNF669 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA CDCA7 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA NRF1 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA FAM171A2 CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA ATL1 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA MLPH CTRPv2 pan-cancer AAC -0.18 5e-07
mRNA HMGN2 CTRPv2 pan-cancer AAC 0.17 5e-07
mRNA GPR137C CTRPv2 pan-cancer AAC 0.17 5e-07
Download CSV